Newsletter Sign UpStay updated on news regarding the Kanzius Foundation and the Kanzius Noninvasive Radiowave Cancer Treatment by receiving our quarterly newsletter, the wave!
Like This PageKanzius Cancer Research Foundation supports research work of investigators at accredited academic institutions whose ultimate goal is to scientifically and clinically prove the efficacy and safety of the Kanzius Noninvasive Radiowave Cancer Treatment. Award funds may only be used to pay for costs that are DIRECTLY allocable to the proposed research project. Payments for indirect expenses associated with the project are not covered. These projects have been approved for funding through a rigorous vetting grant process completed by the Kanzius Cancer Research Foundation Board of Directors and industry experts. The Kanzius Foundation does not accept unsolicited grant requests but will review a Letter of Intent (LOI) if submitted.
 |
Dr. Steven A. Curley, M.D., F.A.C.SThe University of Texas M.D. Anderson Cancer Center |
 |
Dr. David A. Geller, M.D.The University of Pittsburgh Medical Center |
Dr. Steven Curley and Dr. David Geller conduct the reseach of the Kanzius Noninvasive Radiowave Cancer Treatment at the cancer research institutions of the University of Texas M.D. Anderson Cancer Center and The University of Pittsburgh Medical Center. Kanzuis cancer research journals are released for updates on the research of this promising treatment.
Retrieve the published cancer research journals of the Kanzius research team »
